Cancer Causes & Control

, Volume 19, Issue 5, pp 437–442 | Cite as

Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues

  • Marko Lens
  • Veronique Bataille
Review Article



About one third of all melanoma in women occur during their childbearing age. An association between melanoma and hormonal and reproductive factors remains controversial.


This article reviews current evidence on the link between melanoma and reproductive factors. A comprehensive search of Medline (from 1966 to July 2007) and Embase (1974 to July 2007) was performed. Articles were reviewed and additional references were obtained from the bibliographies.


Several controversial issues have been discussed. A pooled analysis of 10 case–control studies including a total of 5,590 women found a lack of association between melanoma risk and pregnancy. Data suggested that women with higher parity (five or more live births) had moderately lower melanoma risk compared with nulliparous women. Current evidence demonstrated that pregnancy did not appear to affect survival in women with melanoma. Based on the current evidence there is no reason to recommend deferral of subsequent pregnancy in women in whom a primary melanoma is diagnosed during pregnancy. The data revealed no relation between melanoma risk and use of oral contraceptives and hormone replacement therapy (HRT).


Exogenous or endogenous female hormones do not contribute significantly to increased risk of melanoma. Melanoma prognosis does not appear to be affected by pregnancy. Termination of pregnancy in women diagnosed with a primary melanoma during pregnancy is not recommended. There is no evidence to support deferral of pregnancy in women with melanoma history except that at the end of 2 years patients have a better estimate of their risk of recurrence.


Melanoma Hormones Reproductive factors Pregnancy 


  1. 1.
    Marks R (2000) Epidemiology of melanoma. Clin Exp Dermatol 25:459–463PubMedCrossRefGoogle Scholar
  2. 2.
    Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150(2):179–185PubMedCrossRefGoogle Scholar
  3. 3.
    Whiteman DC, Stickley M, Watt P, Hughes MC, Davis MB, Green AC (2006) Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 24(19):3172–3177PubMedCrossRefGoogle Scholar
  4. 4.
    Colbourn DS, Nathanson L, Belilos E (1989) Pregnancy and melanoma. Semin Oncol 16:377–387PubMedGoogle Scholar
  5. 5.
    Potter JF, Schoeneman M (1970) Metastasis of maternal cancer to the placenta and fetus. Cancer 25:380–387PubMedCrossRefGoogle Scholar
  6. 6.
    Matthiasen L, Berg G (1989) Malignant melanoma, the most common cancer type, first appearing during pregnancy. Läkartidningen 86:2845–2848Google Scholar
  7. 7.
    Garbe C (1993) Pregnancy, hormone preparations and malignant melanoma. Hautarzt 44:347–352PubMedGoogle Scholar
  8. 8.
    Smith RS, Randall P (1969) Melanoma during pregnancy. Obstet Gynecol 34:825–829PubMedGoogle Scholar
  9. 9.
    Dillman RO, Vandermolen LA, Barth NM, Bransford KJ (1996) Malignant melanoma and pregnancy. West J Med 164:156–161PubMedGoogle Scholar
  10. 10.
    Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B et al (2004) Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 22(21):4369–4375PubMedCrossRefGoogle Scholar
  11. 11.
    Ariel IM (1980) Theories regarding the cause of malignant melanoma. Surg Gynecol Obstet 150:907–917PubMedGoogle Scholar
  12. 12.
    Karagas MR, Zens MS, Stukel TA, Swerdlow AJ, Rosso S, Osterlind A et al (2006) Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control 17(1):11–19PubMedCrossRefGoogle Scholar
  13. 13.
    Kaae J, Andersen A, Boyd HA, Wohlfahrt J, Melbye M (2007) Reproductive history and cutaneous malignant melanoma: a comparison between women and men. Am J Epidemiol 165(11):1265–1270PubMedCrossRefGoogle Scholar
  14. 14.
    Pack GT, Scharnagel IM (1951) Prognosis of malignant melanoma in pregnant women. Cancer 4:324–334PubMedCrossRefGoogle Scholar
  15. 15.
    Sutherland CM, Loutfi A, Mather FJ, Carter RD, Krementz ET (1983) Effect of pregnancy upon malignant melanoma. Surg Gynecol Obstet 157:443–446PubMedGoogle Scholar
  16. 16.
    Trapeznikov NN, Khasanov SR, Iavorskii VV (1987) Melanoma of the skin and pregnancy. Voproxy Onkologii 33:40–46Google Scholar
  17. 17.
    Byrd BF, McGanty WJ (1954) Effect of pregnancy on clinical course of melanoma. Southeastern Med J 47:196–200Google Scholar
  18. 18.
    Holly EA (1986) Melanoma and pregnancy. Recent Results Cancer Res 102:118–126PubMedGoogle Scholar
  19. 19.
    Houghton AM, Flannery J, Viola MV (1981) Malignant melanoma of the skin occurring during pregnancy. Cancer 48:407–410PubMedCrossRefGoogle Scholar
  20. 20.
    Reintgen DS, McCarty KS Jr, Vollmer R, Cox E, Seigler HF (1985) Malignant melanoma and pregnancy. Cancer 55:1340–1344PubMedCrossRefGoogle Scholar
  21. 21.
    McManamny DS, Moss ALH, Pocock PV, Briggs JC (1989) Melanoma and pregnancy: a long-term follow-up. Br J Obstet Gynaecol 96:1419–1423PubMedGoogle Scholar
  22. 22.
    Wong JH, Sterns EE, Kopald KH, Nizze JA, Morton DL (1989) Prognostic significance of pregnancy in stage I melanoma. Arch Surg 124:1227–1231PubMedGoogle Scholar
  23. 23.
    Slingluff CL Jr, Reintgen DS, Volmer RT, Seigler HF (1990) Malignant melanoma arising during pregnancy—a study of 100 patients. Ann Surg 211:552–559PubMedCrossRefGoogle Scholar
  24. 24.
    MacKie RM, Bufalino R, Morabito A, Sutherland C, Cascinelli N (1991) Lack of effect of pregnancy on outcome of melanoma—the World Health Organisation melanoma programme. Lancet 337:653–655PubMedCrossRefGoogle Scholar
  25. 25.
    O’Meara AT, Cress R, Xing G, Danielsen B, Smith LH (2005) Malignant melanoma in pregnancy. A population-based evaluation. Cancer 103(6):1217–1226PubMedCrossRefGoogle Scholar
  26. 26.
    Martin AG, Leal-Khouri S (1992) Physiologic skin changes associated with pregnancy. Int J Dermatol 31:375–378PubMedCrossRefGoogle Scholar
  27. 27.
    Pennoyer JW, Grin CM, Driscoll MS, Dry SM, Walsh SJ, Gelineau JP et al (1997) Changes in size of melanocytic nevi during pregnancy. J Am Acad Dermatol 36(3 Pt 1):378–382PubMedCrossRefGoogle Scholar
  28. 28.
    Travers RL, Sober AJ, Berwick M, Mihm MC Jr, Barnhill RL, Duncan LM (1995) Increased thickness of pregnancy-associated melanoma. Br J Dermatol 132(6):876–883PubMedCrossRefGoogle Scholar
  29. 29.
    Resnick R (1999) Cancer during pregnancy. N Engl J Med 341:120–121CrossRefGoogle Scholar
  30. 30.
    Leslie KK, Espey E (2005) Oral contraceptives and skin cancer: is there a link? Am J Clin Dermatol 6(6):349–355PubMedCrossRefGoogle Scholar
  31. 31.
    Feskanich D, Hunter DJ, Willett WC, Spiegelman D, Stampfer MJ, Speizer FE et al (1999) Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 81(5):918–923PubMedCrossRefGoogle Scholar
  32. 32.
    Pfahlberg A, Hassan K, Wille L, Lausen B, Gefeller O (1997) Systematic review of case–control studies: oral contraceptives show no effect on melanoma risk. Public Health Rev 25:309–315PubMedGoogle Scholar
  33. 33.
    Karagas MR, Stukel TA, Dykes J, Miglionico J, Greene MA, Carey M et al (2002) A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use. Br J Cancer 86(7):1085–1092PubMedCrossRefGoogle Scholar
  34. 34.
    Durvasula R, Ahmed SM, Vashisht A, Studd JW (2002) Hormone replacement therapy and malignant melanoma: to prescribe or not to prescribe? Climacteric 5(2):197–200PubMedCrossRefGoogle Scholar
  35. 35.
    Grin CM, Driscoll MS, Grant-Kels JM (1998) The relationship of pregnancy, hormones, and melanoma. Semin Cutan Med Surg 17(3):167–171PubMedCrossRefGoogle Scholar
  36. 36.
    Baergen RN, Johnson D, Moore T et al (1997) Maternal melanoma metastatic to the placenta: a case report and review of the literature. Arch Pathol Lab Med 121:508–511PubMedGoogle Scholar
  37. 37.
    Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ et al (2003) Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol 21(11):2179–2186CrossRefGoogle Scholar
  38. 38.
    Anderson JF, Kent S, Machin GA (1989) Maternal malignant melanoma with placental metastasis: a case report with literature review. Pediatr Pathol 9:35–42PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  1. 1.Twin Research and Genetic Epidemiology UnitKing’s College LondonLondonUK
  2. 2.Dermatology DepartmentWest Herts NHS TrustHertfordshireUK

Personalised recommendations